.@ERStalk Environ & Health committee workshop concludes: HCPs vital to raising awareness of air pollution to patients http://ow.ly/pfOe301FoIg.
This paper considers how best to achieve patient and public involvement in research and how to get the most out of it http://ow.ly/R0hwV.
KEY POINTS Although there are many patient organisations in Europe, this is not the case in all countries across the globe.Access to care is one of the main global issues highlighted by the European Lung Foundation International Patient Advisory Committee.The European Respiratory Society/European Lung Foundation Healthy Lungs for Life campaign can be used… (More)
Lymphangioleiomyomatosis (LAM) is a rare lung disease that almost exclusively affects women and develops in about one in 400 000 adult females. The European Lung Foundation worked closely with one of the patient organisations within its network, the European LAM Federation, to raise awareness of LAM at the 2014 European Respiratory Society International… (More)
This study aimed to gain insight into the impact of lung conditions on smoking behaviour and smoking cessation, and identify recommendations for smoking cessation and professional-patient communications. The study was led by the European Lung Foundation in collaboration with the European Respiratory Society Task Force on "Statement on smoking cessation on… (More)
ERS/ELF say "take the active option" for Healthy Lungs for Life http://ow.ly/R1WaX.
Patients are included, welcomed and integrated at the ERS International Congress http://ow.ly/UpV8A.
The paper reports findings from empirical research conducted across a range of supply networks. Three key research questions are addressed, one at the level of the firm, one at the supply chain level, one at the national level. Risk is seen to take different forms at each level of intervention.